Bugworks Research Inc. CSO Dr. Santanu Datta underscores need for a Bayh-Dole like Act to propel research commercialization
Bugworks Research starts first human dose study to treat critical bacterial infections - ETHealthWorld
Bugworks Research begins first in human phase 1 study of BWC0977 to treat critical bacterial infections
Indian innovation at work: Bugworks embarks on phase I trials in its pursuit for a new antibiotic
Bugworks is proud to announce First in Human phase 1 studies of BWC0977 for the treatment of critical bacterial infections - first novel broad spectrum in decades
Dr. Santanu Datta explores the future of drug development and the tension between access and excess
Bugworks Co-Founder Bala Subramanian features in the FORBES India Marquee edition on ‘Leaders by Example”
Bugworks one of four global companies exemplified in this latest AMR report from Access to Medicines Foundation
G7 health ministers make AMR an important facet of pandemic preparedness and vow to incentivise this space
Bugworks featured amongst the top 5 innovative Biotech companies to look out for in India by Pharmareg News.
Bugworks secures support from US Government's Defense Threat Reduction Agency (DTRA) to validate its clinical asset against the toughest bacterial biothreats
Dr. Oppel Greeff, Bugworks’ investor and member of SAB, wins the prestigious Havengaprize by the South Africa Academy of Art and Science
Bugworks’ CEO interviewed by the Financial Express as part of a story done on World innovation day!
Anand Anandkumar, Bugworks’ CEO has been re-nominated into the Board of AMR Industry Alliance and will serve as key member of the Biotech Working Group within this global alliance.
Anand Anandkumar has been selected by CEO Insights Magazine for 'Top 10 Best Leaders in Biotechnology in India 2021'
Bugworks on BBC’s people fixing the world podcast.
Bugworks Research, one of the three companies to be showcased in GlobalBioIndia event 2021.
Japanese venture company UTEC - The University of Tokyo Edge Capital Partners is enabling world class innovation from India in lifesciences - Bugworks Research Inc. as an exemplar!
ALCOR Fund has chosen Bugworks as one of top 10 most innovative biotech startups in India
Bugworks showcased as pioneering start-up in Indian biotech, attracting global funding.
Dr.Anand Anandkumar Co-Founder and CEO of Bugworks Research Inc. has been inducted into Basel area innovation India Board (BIIB).
